Back to search

North Dakota State University

Establishing and Characterizing Patient-Derived Breast Cancer Cell Lines

Abstract

dc:description.abstract

Commercial cancer cell lines have long been extensively used as an important platform to study cancer. They have contributed to a plethora of discoveries in the field of cancer research. However, there are limitations with using these cell lines, such as induced mutations over the long-term in vitro culture. These mutations cause incorrect exhibition of the in vivo characteristics of the cancer cells. Here, we focused on establishing Patient-derived breast cancer cell lines and attempted to characterize them in terms of several biomarkers that are shown to be overexpressed in breast cancer cells. Patient-derived breast cancer cell lines are more reliable tools to study the molecular and cellular processes taking place in vivo, since they are freshly isolated from the tumor biopsy and do not undergo induced immortalization. We explored the CK19, Ki67, vimentin, EpCAM, E-cadherin, and N-cadherin expression in three successfully established patient-derived breast cancer cell lines.

Degree

thesis:*
Grantor dc:publisher
North Dakota State University
Year dc:date.issued
2022

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Mohammadi, Farid Solaymani

Rights

dc:rights
Statement dc:rights
  • NDSU policy 190.6.2

Identifiers

dc:identifier.*
Handle dc:identifier.uri
https://hdl.handle.net/10365/33342

Chain of custody

source
Harvested from
North Dakota State University
Base URL
library.ndsu.edu/server/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
related terms
citation

Mohammadi, Farid Solaymani. Establishing and Characterizing Patient-Derived Breast Cancer Cell Lines. North Dakota State University, 2022. https://hdl.handle.net/10365/33342